STOCK TITAN

Carmell Corporation Warrant (CTCXW) Stock Price, News & Analysis

CTCXW NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
67 97 sessions, March 7, 2024 to March 7, 2025
Largest daily move
+91.6% close of December 13, 2024
1-month change
-27% closing prices, February 7, 2025 to March 7, 2025

Company Description

CTCXW represents the publicly traded redeemable warrants that were originally issued in connection with Carmell Corporation, a company described as a bio-aesthetics business. According to a corporate announcement, Carmell Corporation has undertaken a rebranding and name change to Longevity Health Holdings, Inc., with its common stock and redeemable warrants beginning to trade under new symbols.

The company announcement states that Carmell Corporation, identified by the symbols CTCX and CTCXW on Nasdaq, changed its corporate name to Longevity Health Holdings, Inc.. In the same announcement, it is noted that the company’s common stock and redeemable warrants began trading under the symbols XAGE and XAGEW, respectively, at the open of trading on March 10, 2025. This means that CTCXW functions as a historical ticker for the warrants associated with the entity that is now known as Longevity Health Holdings, Inc.

The company is described in the announcement as a bio-aesthetics company with a business focus on longevity and healthy aging. The communication explains that the new corporate name is intended to reflect this focus on longevity and healthy aging and to align the market and investor-facing identity with its business direction and growth strategy. It also mentions that the company’s strategy includes growth through acquisitions and strategic partnerships in addition to organic growth of its existing business.

The announcement refers to the company’s allogeneic PRP Secretome technology, which it characterizes as a scientific advancement in regenerative bio-aesthetics. It also notes that the company completed an acquisition of Elevai Skincare, Inc., which brought in a commercial product pipeline based on stem cell exosome technology. The announcement further indicates that branding for existing marketed products remained unchanged following the rebranding.

Because CTCXW is a historical symbol tied to Carmell Corporation prior to the rebranding to Longevity Health Holdings, Inc., investors and researchers using this page are typically looking for background on the warrants that were associated with the former Carmell identity and for context on how those warrants relate to the company now trading under the XAGE and XAGEW symbols.

Business focus and strategic direction

In the rebranding announcement, the company’s leadership states that the new name Longevity Health Holdings, Inc. reflects a business focus that includes bio-aesthetics and a broader emphasis on longevity and healthy aging. The statement also mentions possible future expansion into segments such as diagnostics and nutrition, and describes a growth strategy that involves acquisitions and strategic partnerships along with the development of existing operations.

The company highlights two technology-related elements in the same communication: its allogeneic PRP Secretome technology for regenerative bio-aesthetics and the stem cell exosome technology associated with Elevai Skincare, Inc. These references indicate that the company links its bio-aesthetics and longevity positioning to these underlying scientific and technological approaches.

Historical context for CTCXW

CTCXW is identified in the announcement as the symbol for the company’s redeemable warrants when the corporate name was Carmell Corporation. The same document explains that, as part of the rebranding, those redeemable warrants began trading under the symbol XAGEW on March 10, 2025. As a result, CTCXW should be understood as a former warrant symbol that is now associated historically with Carmell Corporation prior to its transition to Longevity Health Holdings, Inc.

Users researching CTCXW may be interested in understanding that the warrants originally tied to Carmell Corporation are now referenced under XAGEW following the rebranding. The announcement does not provide additional structural details about the warrants themselves but does make clear the relationship between the old and new symbols.

Industry classification

The sector information provided for this page associates the company with the Surgical & Medical Instruments & Apparatus sector. The company’s own announcement, however, describes it as a bio-aesthetics company with a focus on longevity and healthy aging. Together, these references position the historical CTCXW warrants within the context of a business that connects medical or bio-aesthetic technologies with applications in appearance and aging.

Stock Performance

$0.0267
No recent trading
Last close: March 7, 2025
-33.2%
Year to March 7, 2025

Carmell Corporation Warrant (CTCXW) closed at $0.0267 on March 7, 2025. In the year to March 7, 2025, the price lost 33.2%.

See what a $1,000 investment in CTCXW would be worth today

Average down calculator for CTCXW

CTCXW Metrics & Rankings

Price returns through March 7, 2025. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Carmell Corporation Warrant has 1 recent news article. View all CTCXW news →

SEC Filings

No SEC filings available for CTCXW.

CTCXW Company Profile & Sector Positioning

Carmell Corporation Warrant (CTCXW) and is listed on the NASDAQ.

Frequently Asked Questions

Carmell Corporation Warrant (CTCXW) has no recent trading. Its last close was $0.0267 on March 7, 2025.

According to the company’s announcement, CTCXW was the Nasdaq symbol for the redeemable warrants of Carmell Corporation, a bio-aesthetics company that later changed its corporate name to Longevity Health Holdings, Inc.

In the rebranding communication, the company explains that the new name Longevity Health Holdings, Inc. reflects a focus on longevity and healthy aging, encompassing its bio-aesthetics activities and possible future expansion into areas such as diagnostics and nutrition.

The announcement describes the company’s allogeneic PRP Secretome technology as representing a scientific advancement in regenerative bio-aesthetics, positioning it as part of the company’s bio-aesthetic and longevity focus.

The announcement reports that the company acquired Elevai Skincare, Inc. in January 2025 and that this acquisition delivered a commercial product pipeline based on stem cell exosome technology, which complements the company’s existing bio-aesthetics activities.

The company states that its growth strategy is based on acquisitions and strategic partnerships in addition to organic growth of its existing business, aligning with its focus on longevity and healthy aging.

The company’s announcement indicates that, at the open of trading on March 10, 2025, the redeemable warrants began trading under the symbol XAGEW, which suggests that CTCXW is a historical symbol and that XAGEW is the updated listing for those warrants.

The sector information on this page associates the company with Surgical & Medical Instruments & Apparatus, while the company’s announcement describes it as a bio-aesthetics business focused on longevity and healthy aging, indicating a connection between medical or bio-aesthetic technologies and aging-related applications.